# A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

> **NCT04976595** · PHASE4 · UNKNOWN · sponsor: **Acerus Pharmaceuticals Corporation** · enrollment: 218 (estimated)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Natesto

## Key facts

- **NCT ID:** NCT04976595
- **Lead sponsor:** Acerus Pharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976595, "A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04976595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*